Mohammed Salah Ayoup*a,
Yasmin Wahbya,
Hamida Abdel-Hamida,
Marwa M. Abu-Serieb,
Sherif Ramadancd,
Assem Barakat*e,
Mohamed Telebf and
Magda M. F. Ismailg
aChemistry Department, Faculty of Science, Alexandria University, P. O. Box 426, Alexandria, 21321, Egypt. E-mail: mohammedsalahayoup@gmail.com; Mohamed.salah@alexu.edu.eg
bMedical Biotechnology Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Egypt
cChemistry Department, Michigan State University, East Lansing, MI 48824, USA
dDepartment of Chemistry, Benha University, Benha, Egypt
eDepartment of Chemistry, College of Science, King Saud University, P. O. Box 2455, Riyadh 11451, Saudi Arabia. E-mail: ambarakat@ksu.edu.sa
fDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt
gDepartment of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, 11754, Egypt
First published on 11th December 2024
Correction for ‘Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer’ by Mohammed Salah Ayoup et al., RSC Adv., 2023, 13, 27722–27737, https://doi.org/10.1039/d3ra04029a.
In addition, while reviewing raw images, it was noticed that other raw images (4-treated breast cancer cells and 8-treated MCF7 cells) were not correctly placed in their corresponding panels in the final Fig. 2.
The figure should have been:
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2024 |